Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Julianna Tatelbaum"


25 mentions found


Julianna Tatelbaum: Put Your Ambition Out There
  + stars: | 2024-01-30 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJulianna Tatelbaum: Put Your Ambition Out There"Talk to people and put your ambition out there; more often than not, you will find people who are willing to help." Street Signs Europe anchor Julianna Tatelbaum shares what ambition means to her.
Persons: Julianna Tatelbaum
BRAZIL - 2021/11/26: In this photo illustration a F. HoffmannLa Roche AG logo is seen on a screen and a hand holding a pill. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images)Swiss pharmaceuticals giant Roche is set to acquire anti obesity drug developer Carmot Therapeutics, becoming the latest company to attempt to unseat Novo Nordisk and Eli Lilly's dominance within the global weight-loss drugs market. The U.S. takeover target's early-stage technology could help crack highly prized oral obesity treatments, Roche Pharmaceuticals CEO Teresa Graham said Monday, but it may be several years before the drugs are widely available. The deal will provide Roche access to Carmot's current research and development portfolio, including all clinical and preclinical assets. Shares of the Swiss company, which have been in the doldrums this year, were up 2.25% following the news of the acquisition.
Persons: HoffmannLa Roche, Rafael Henrique, Roche, Eli Lilly's, Teresa Graham, we'll, Graham, CNBC's Julianna Tatelbaum, Eli Lilly's Mounjaro Organizations: Getty Images, Carmot Therapeutics, Novo Nordisk, U.S, Roche Pharmaceuticals, Roche Locations: BRAZIL, Swiss, California
watch nowLONDON — With big productions always needing big money, one theater expert explains how investment in the sector works and how London's West End is used as a testing ground for its New York counterpart. Not-for-profit vs. commercialIn London, there are two main theater models: Not-for-profit venues like the National Theatre, Shakespeare's Globe, and The Old Vic, and commercial theater like in the famous West End. Stakes higher in New YorkThe bar for financial success is much lower in London than on Broadway in New York. Budgets for shows in the West End can reach millions while on Broadway in New York, the stakes are even higher. Often producers will run productions in London first and if they are received well, transfer them to New York.
Persons: Eleanor Lloyd, Lloyd, it's Organizations: New, Society of London Theatre, National Theatre, Shakespeare's Globe, Broadway, Big Apple Locations: London, New York
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLondon's iconic West End acts as a testing ground for Broadway investmentLive events took a massive hit during the Covid-19 pandemic but now audiences are rushing back to sporting events, concerts, and live theater. CNBC's Julianna Tatelbaum reports.
Persons: CNBC's Julianna Tatelbaum Organizations: Broadway
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. Michael Siluk | UCG | Getty ImagesNovo Nordisk said Thursday that its blockbuster weight-loss drug Wegovy could receive expanded approval from the U.S. Food and Drug Administration within six months. "I would say from today, [the outcome will be] less than six months," Knudsen told CNBC's Julianna Tatelbaum on "Street Signs." watch nowEarlier Thursday, Novo Nordisk in its third-quarter earnings announced plans to get expanded approval from the FDA, but shared no timeline. "The SELECT study is, in an obese population with established cardiovascular disease, does Wegovy reduce cardiovascular risk?
Persons: Michael Siluk, Karsten Munk Knudsen, Knudsen, CNBC's Julianna Tatelbaum, " Knudsen, Novo Organizations: UCG, Getty, Novo Nordisk, U.S . Food, Drug Administration, CNBC, FDA, Novo Nordisk's Locations: U.S, Danish
China has changed the world's energy system before and is set to do so again, as a peak in demand for fossil fuels nears, according to the International Energy Agency's Executive Director. Fatih Birol said that there was one country behind the substantial increase in global fossil fuel consumption over the last decade: China. "China changed the global energy system in the last 10 years. He described this as one of two "important drivers" behind the IEA's belief that global demand for fossil fuels will peak by 2030. The comments come after the IEA published its World Energy Outlook 2023, a major report on the global energy system.
Persons: Fatih Birol, CNBC's Julianna Tatelbaum Organizations: International Energy Agency's, IEA, Energy Locations: China
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHow brand partnerships are helping shape AEG's festival experiencesCNBC's Julianna Tatelbaum uncovers the importance of brand collaborations to AEG's festival experiences and looks at why marketers are favouring partnerships over sponsorships
Persons: Julianna Tatelbaum
How AEG is changing the festival demographic
  + stars: | 2023-10-12 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHow AEG is changing the festival demographicCNBC's Julianna Tatelbaum explores how live music events company AEG Presents is changing the festival offering to appeal to a wider audience beyond the 18-30 demographic.
Persons: Julianna Tatelbaum Organizations: AEG
Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines. Novartis on Wednesday completed the spinoff of its generics and biosimilars business Sandoz, whose shares began trading at 24 Swiss francs in the early minutes of the company's debut on the SIX Swiss Exchange. The Swiss drugmaker initially announced intentions to spin off the business in August, offering stakeholders one Sandoz share for every five Novartis shares via a dividend-in-kind distribution. Pure play companies refer to entities that target a single product or industry sector. Novartis shares climbed more than 3% in early trade in Zurich to lead the pan-European Stoxx 600 index .
Persons: Sandoz, Narasimhan, we've, CNBC's Julianna Tatelbaum Organizations: Novartis, Wednesday, SIX Swiss Exchange, CNBC Locations: Swiss, Zurich
Musk vs. Zuck, CNBC Style: The gloves are off
  + stars: | 2023-06-23 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMusk vs. Zuck, CNBC Style: The gloves are offCNBC's Julianna Tatelbaum and Steve Sedgwick pit Tesla against Meta as the Elon Musk vs. Mark Zuckerberg cage fight meme goes viral.
Persons: Julianna Tatelbaum, Steve Sedgwick, Mark Zuckerberg Organizations: CNBC, Meta, Elon
What do vegan egg and shrimp alternatives taste like?
  + stars: | 2023-04-21 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWhat do vegan egg and shrimp alternatives taste like? With the plant-based food market value estimated to triple by 2030, global food giant Nestlé is investing heavily into the research and development of vegan products. CNBC's Julianna Tatelbaum was given a rare tour of company's R&D center in Lausanne, Switzerland, where she sampled surprisingly plant-based versions of some everyday favorites.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailHow Nestlé is futureproofing its coffee business from bean to cupCNBC's Julianna Tatelbaum visits Nestlé's Institute of Agricultural Sciences in Lausanne, Switzerland, to see how the global food and drinks giant is futureproofing its coffee product portfolio.
Nestlé R&D lead on the products and packaging of the future
  + stars: | 2023-04-21 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNestlé R&D lead on the products and packaging of the futureCNBC's Julianna Tatelbaum gets special rare access to Nestlé's research and development center in Lausanne, Switzerland, where scientists are working to increase sustainability across the entire portfolio.
Wegovy is one of several new "miracle" drugs that promise to revolutionize the weight-loss industry. You're getting 15 to 17 approaching 20% weight loss with a weekly injection," Peter Verdult, a pharmaceuticals analyst at Citi, told CNBC. A report by the World Health Organization in 2022 showed that obesity has nearly tripled since 1975 and continues to rise. More than 1 billion people are clinically obese globally, of whom 650 million are adults, 340 million are adolescents and 39 million are children. But the long-term consequences of these drugs remain unknown.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWhy the Dutch are leaders in water defense innovationAs the climate changes, sea levels are predicted to rise, and extreme weather events are set to increase in frequency and intensity. But one European country may have the answer to keeping water at bay. CNBC's Julianna Tatelbaum travels to the Netherlands to find out more.
Inside the world’s largest floating office
  + stars: | 2023-03-24 | by ( Julianna Tatelbaum | ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailInside the world’s largest floating officeCNBC's Julianna Tatelbaum travels to the world's largest floating office to see if working on water could be a sustainable design solution for rising sea levels.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCan working with nature be the answer to rising sea levels? From an internationally renowned experimental facility to a large-scale prototype, CNBC's Julianna Tatelbaum travels to the Netherlands to explore the latest research in natural solutions to flood risk.
All European sectors close in the green today
  + stars: | 2023-03-20 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAll European sectors close in the green todayCNBC's Julianna Tatelbaum joins the 'Halftime Report' to cover European markets after market close.
European markets rally following 50 bps central bank hike
  + stars: | 2023-03-16 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEuropean markets rally following 50 bps central bank hikeCNBC's Julianna Tatelbaum joins the 'Halftime Report' to discuss the fallout from Credit Suisse, Europe's central bank hiking rates and a rally in Europe's markets.
European banks see a sharp sell-off
  + stars: | 2023-03-15 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEuropean banks see a sharp sell-offCNBC's Julianna Tatelbaum, joins the 'Halftime Report' to discuss European banks tumbling, the force behind the Credit Suisse sell-off and Europe's central bank policy.
European banking stocks fall over 4% in early trade Friday
  + stars: | 2023-03-10 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEuropean banking stocks fall over 4% in early trade FridayEuropean banking stocks sink as fears around Silicon Valley Bank spread around the world. CNBC's Julianna Tatelbaum reports.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBIS' Skingsley: Central banks best placed to provide trust in payment systemsCecilia Skingsley, head of the BIS Innovation Hub, speaks to CNBC's Julianna Tatelbaum.
Investors should not expect a cut in interest rates until 2024 thanks to a strong U.S. economy and the potential for a delayed recession, according to the chief global strategist at Principal Global Investors. In fact, the Federal Reserve keeping interest rates higher for longer is the "scenario that we're looking at now," Shah told CNBC's Julianna Tatelbaum. The employment picture started 2023 on a stunningly strong note , with nonfarm payrolls posting their biggest gain since July 2022 despite a rapid increase in interest rates last year. 'Absolutely no cuts this year' When asked when investors should expect a cut in interest rates, Shah responded that it wouldn't be until 2024. Goldman Sachs expects interest rates to hit 5.38% by the second quarter, with the first cut to 5.13% expected in the first three months of next year.
Nestle plans price hikes after inflation eats into profits
  + stars: | 2023-02-16 | by ( ) www.cnbc.com   time to read: +2 min
He declined to comment on the planned level of price increases, which he said were necessary to offset the damage caused by commodity price rises. That is after all the pricing we have done in 2022," Schneider told reporters. Europe was the company's main drag on margins last year, with Nestle taking a roughly 190 basis point margin hit. Schneider told CNBC: "It had a lot to do with inflation hitting North America earlier, in 2021, and for different reasons. Europe saw a spike in inflation, in energy costs, especially after the invasion of Ukraine.
Europe raced to shore up its energy supplies in the wake of Russia's invasion of Ukraine, and it appears to have averted a worst-case scenario this winter — largely thanks to liquified natural gas. For years, Europe was heavily dependent on Russian pipeline gas. Europe has successfully filled its gas storage capacity to 95%, which means all should be OK this winter. Because Europe was so reliant on Russia, it has limited LNG import capacity. CNBC visited the only LNG terminal in Greece that receives, stores and turns the critical fuel back into gas.
Total: 25